Saw some but not any listing this trial. Given the small size of this trial (yet promising data) I wouldn’t expect them to be eager to go to a conference too. I’ll be looking forward to announcement of the TNBC combo trial. Will be interesting to see if it will be just a p2 trial or a p2/3 trial like PISCES.